(Q46620833)

English

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin

scientific article published on 26 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Raul C Camacho

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

D Brooks Lacy

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

Freyja D James

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

E Patrick Donahue

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

David H Wasserman

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

publication date

26 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

289

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

E1039-43

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Integrated effects of multiple modulators on human liver glycogen phosphorylase a.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Estimation of the rate of appearance in the non-steady state with a two-compartment model

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Calcineurin is required for translational control of protein synthesis in rat pancreatic acini

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR). Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

AMP kinase-induced skeletal muscle glucose but not long-chain fatty acid uptake is dependent on nitric oxide

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR--an activator of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00247.2005

21 January 2018

Identifiers

10.1152/AJPENDO.00247.2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16046457

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46620833&oldid=2122659829"